251, Illinois — Chicago, Illinois

251, Illinois is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

251, Illinois has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Chronic Hepatitis D Infection.

Sponsors: Mirum Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 251, Illinois?

251, Illinois has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 251, Illinois conducted?

251, Illinois has 1 clinical trials on record, with 1 currently active. Their work covers Chronic Hepatitis D Infection.

Is 251, Illinois accredited by Crixeo Health?

251, Illinois has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 251, Illinois?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.